best options for monitoring glp-1 medication 12 Biomarkers To Monitor if You Take a What to Make of the
Description
Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer
Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes
Do not use it if the safety seal is broken or missing
For best results, take for 3-6 months consistently
Phase 2 trials showed significant weight loss up to 20% at 52 weeks
The most commonly reported side effects are mild to moderate gastrointestinal symptoms such as nausea, constipation, and indigestion, and they usually ease as your body adjusts
